COPD Spotlight

Implementing Best Practices in a Changing Treatment Landscape

EP. 7: Michael Hess Reviews Treatments for COPD and Assessing the Effectiveness of Therapies

June 3rd 2022

Respiratory therapist Michael Hess, MPH, RRT, RPFT, discusses the main therapies used for chronic management of chronic obstructive pulmonary disorder (COPD), as well as the decision to escalate to triple therapy.

EP. 6: Dr Nicola Hanania on the Future of COPD Research

March 31st 2021

Nicola Hanania, MD, MS, discusses the future of research on triple therapy and chronic obstructive pulmonary disease (COPD).

EP. 5: Assessing Patient-Reported Treatment Values in COPD

March 15th 2021

Julia Slejko, PhD, and Robert Reed, MD, discuss findings of their recent study on patient-reported value in chronic obstructive pulmonary disease (COPD) treatment management.

EP. 4: COPD & Social Determinants of Health: An Interview With Dr Trisha Parekh

February 25th 2021

Trisha Parekh, DO, discusses her research on the impact of psychological stress on low-income patients with chronic obstructive pulmonary disease (COPD).

EP. 3: Dr Gerard Criner Offers Insights on Early COPD Diagnosis, Next Steps for Triple Therapy

February 15th 2021

Gerard Criner, MD, FACP, FACCP, offers insights on the next steps for triple therapy, challenges of early COPD diagnosis, and how the pandemic could impact long-term lung health.

EP. 2: Dr Antonio Anzueto on the Benefits of Triple Therapy, Importance of Accurate COPD Diagnoses

January 29th 2021

Anzueto, a professor of medicine at the University of Texas Health in San Antonio and clinician practicing pulmonary and clinical care, also serves as a member of the GOLD Science Committee.

EP. 1: COPD & COVID-19: An Interview With Dr MeiLan Han

January 22nd 2021

Meilan King Han, MD, a professor of internal medicine at the University of Michigan, discusses how her practice has altered patient care to adapt to the ongoing pandemic and challenges patients with chronic obstructive pulmonary disease (COPD) and providers face when dealing with a highly contagious airborne respiratory virus.